PT - JOURNAL ARTICLE AU - Brouwer, Andrew F. AU - Jeon, Jihyoun AU - Jimenez-Mendoza, Evelyn AU - Land, Stephanie R. AU - Holford, Theodore R. AU - Friedman, Abigail S. AU - Tam, Jamie AU - Mistry, Ritesh AU - Levy, David T. AU - Meza, Rafael TI - Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017–2019 vs 2019–2021 AID - 10.1101/2023.10.20.23297320 DP - 2023 Jan 01 TA - medRxiv PG - 2023.10.20.23297320 4099 - http://medrxiv.org/content/early/2023/10/21/2023.10.20.23297320.short 4100 - http://medrxiv.org/content/early/2023/10/21/2023.10.20.23297320.full AB - Introduction The use of cigarettes and electronic nicotine delivery system (ENDS) has likely changed since 2019 with the rise of pods and disposables, the outbreak of lung injuries related to vaping THC, flavor bans, and the COVID pandemic. We analyzed patterns of initiation, cessation, and transitions between cigarettes, ENDS, and dual use before and after 2019.Methods Using the Population Assessment of Tobacco and Health (PATH) Study, we applied a multistate transition model to 28,061 adults in Waves 4–5 (2017–19) and 24,751 adults in Waves 5–6 (2019–21), estimating transition rates for initiation, cessation, and switching products for each period overall and by age group.Results Cigarette initiation among adults who never used either product decreased from 2017–19 to 2019–21, but ENDS initiation did not significantly change. Persistence of ENDS-only use remained high, with 75–80% still using ENDS only after 1 year. Cigarette-only use transitions remained similar, with about 88% remaining, 7% transitioning to non-current use, and 5% transitioning to dual or ENDS-only use. In contrast, dual use to ENDS-only transitions increased from 9.5% (95%CI: 7.3–11.7%) to 20.1% (95%CI: 17.5–22.7%) per year from 2017–19 to 2019–21, decreasing the persistence of dual use. The dual use to cigarette-only transition remained at about 25%. These changes were qualitatively similar across adult age groups, though adults ages 18–24 years exhibited the highest probability of switching from cigarette-only use to dual use and from dual use to ENDS-only use.Conclusions Persistence of ENDS use among adults remained high in 2019–21, but a larger fraction of dual users transitioned to ENDS-only use compared to 2017–19. Because the fraction of cigarette-only users switching to dual use remained low, the public health implications of the increased dual use to ENDS-only transition are minimal.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Cancer Institute (NCI) and Food and Drug Administration (FDA) grant U54CA229974.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Michigan Institutional Review Board waived ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesMost data are available in a public, open access repository. Other data may be obtained from a third party and are not publicly available. Public Use Files from the Population Assessment of Tobacco and Health Study are available for download from an open access repository (https://doi.org/10.3886/ICPSR36498.v18). Restricted-use files (https://doi.org/10.3886/ICPSR36231.v37) require a restricted data use agreement. Conditions of use are available on the aforementioned websites.